ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TRDA Entrada Therapeutics Inc

13.56
0.31 (2.34%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 67,224
Bid Price 12.27
Ask Price 13.70
News -
Day High 13.59

Low
10.62

52 Week Range

High
18.44

Day Low 12.72
Share Name Share Symbol Market Stock Type
Entrada Therapeutics Inc TRDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.31 2.34% 13.56 19:00:00
Open Price Low Price High Price Close Price Previous Close
13.40 12.72 13.59 13.56 13.25
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,181 67,224 US$ 13.26 US$ 891,253 - 10.62 - 18.44
Last Trade Type Quantity Price Currency
15:05:16 formt 100 US$ 13.20 USD

Entrada Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
454.62M 33.60M - 129.01M -6.69M -0.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Entrada Therapeutics News

Date Time Source News Article
3/13/202406:00GlobeNewswire Inc.Entrada Therapeutics Reports Fourth Quarter and Full Year..
3/08/202415:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/06/202415:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/05/202418:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/07/202406:00GlobeNewswire Inc.Entrada Therapeutics to Present at Upcoming Investor..
1/03/202406:16Edgar (US Regulatory)Form 8-K - Current report
1/03/202406:00GlobeNewswire Inc.Entrada Therapeutics Promotes Nathan J. Dowden to President
12/26/202315:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRDA Message Board. Create One! See More Posts on TRDA Message Board See More Message Board Posts

Historical TRDA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.2613.5911.7812.5266,1481.3010.60%
1 Month14.0814.33511.7812.7878,883-0.52-3.69%
3 Months14.0015.56511.3513.1580,232-0.44-3.14%
6 Months16.0517.5810.750113.9783,022-2.49-15.51%
1 Year12.5118.4410.6214.3880,3851.058.39%
3 Years26.5036.855.1215.1487,497-12.94-48.83%
5 Years26.5036.855.1215.1487,497-12.94-48.83%

Entrada Therapeutics Description

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.

Your Recent History

Delayed Upgrade Clock